Skip to main content
TipRanks
Go Ultimate75% OFF

Andros Pharmaceuticals Co., Ltd. (6917) Cash flow

Andros Pharmaceuticals Co., Ltd. Cash Flow

TW:6917's free cash flow for Q2 2026 was NT$-25.46M. For the 2026 fiscal year, TW:6917's free cash flow was increased by NT$0.00 and operating cash flow was NT$-25.46M. See a summary of the company’s cash flow.

Cash Flow
Cash FlowDec 25Dec 24Dec 23Dec 22Dec 21
NT$ -45.45MNT$ -78.90MNT$ -46.64MNT$ -35.76MNT$ -35.87M
NT$ -107.95MNT$ -147.51MNT$ -27.33MNT$ -137.79MNT$ 25.90M
NT$ 169.83MNT$ -5.10MNT$ 255.01MNT$ 247.12MNT$ 9.23M
NT$ 53.76MNT$ 38.85MNT$ 269.01MNT$ 88.19MNT$ 14.63M
NT$ -46.44MNT$ -83.42MNT$ -47.22MNT$ -35.80MNT$ -35.87M

Currency in TWD

Andros Pharmaceuticals Co., Ltd. Cash Flow

-200M-100M0100M200M300M2019202020212022202320242025OperatingInvestingFinancing